Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: The possible role in immune privilege

Clinical and Experimental Immunology

Volumn 123, Issue 3, 2001, Pages 481-486

  Ohshima, K ^a   Nakashima, M ^a   Sonoda, K ^a   Kikuchi, M ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

FasL; NK cells; Pregnancy; RCAS1

Indexed keywords

FAS LIGAND; HLA ANTIGEN CLASS 1; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FETUS WASTAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREGULATION; NATURAL KILLER CELL; PREGNANCY; PRIORITY JOURNAL; TROPHOBLAST; UTERUS;

ABORTION, SPONTANEOUS; ADULT; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CURETTAGE; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; TROPHOBLASTS; UTERUS;

EID: 0035069277     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01461.x     Document Type: Article

References (30)

1. Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates
2. Is restricted antigen presentation the explanation of fetal allograft survival?
3. Mallet VHLA-G, and pregnancy
4. FasLigand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus
5. T cell awareness of paternal alloantigens during pregnancy
6. The immunology of pregnancy
7. Human trophoblasts and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule
8. HLA class I expression on the materno-fetal interface
9. First trimester human endovascular trophoblast cells express both HLA-C and HLA-G
10. Unravelling immune privilege
11. Expression of Fas-ligand in first trimester and term human placental villi
12. Human uterine natural killer cells
13. Decidual natural killer cytotoxicity decreased in normal pregnancy but not in anembryonic pregnancy and recurrent spontaneous abortion
14. Accounting for the peripartum loss of granulated metrial gland cells, a natural killer cell population, from the pregnant mouse uterus
15. T cell defined tumor antigens
16. Serological identification of human tumor antigens
17. Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand- expressing tumor cells - A mechanism of immune evasion?
18. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1
19. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas
20. Relationship between FasLigand expression on carcinoma cell and cytotoxic T-lymphocyte response in lympoepithelioma-like cancer of the stomach
21. Complement and pregnancy: New insight into the immunology of the fetomaternal relationship
22. The pregnant woman, placenta, fetus, and infectious agents
23. Profile of cytokine mRNA expression in periplantation human endometrium
24. Molecular cloning and expression of the FasLigand, a novel member of the tumor necrosis factor family
25. A role for CD95 ligand in preventing graft rejection
26. Labor-associated changes in Fas ligand expression and function in human placenta
27. Abundant perforin expression at the maternal-fetal interface: Guarding the semiallogeneic transplant?
28. Fas and pefforin pathways as major mechanisms of T cell-mediated cytotoxicity
29. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A
30. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix